Evidence Synthesis
KMSMEDI Sees Accelerating Growth Indicators, With Gross Margin Notably Improving The Indian equity market is witnessing a shift in KMSMEDI's performance, with several key metrics indicating an upward trend.
Evidence Synthesis
Last synthesized: 5 Sept 2026, 04:21
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
KMSMEDI Sees Accelerating Growth Indicators, With Gross Margin Notably Improving The Indian equity market is witnessing a shift in KMSMEDI's performance, with several key metrics indicating an upward trend.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 27.74 % | 2.1 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 2.1 % | 2.01 | ▲ |
| REVENUE_GROWTH_YOY | -8.7 % | -96.1 | ▲ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 2,000 shares | 0 | ▲ |
| CLOSE_PRICE | 132.8 INR | 132.8 | - |